Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Consolidated Statements of Operations [Abstract]    
Revenue    $ 11,931
Operating expenses:    
Research and development 3,639,757 3,943,714
Selling, general and administrative 3,364,490 2,574,630
Total operating expenses 7,004,247 6,518,344
Loss from operations (7,004,247) (6,506,413)
Other income (expense):    
Interest income 1,497 9,733
Interest expense (363,082) (293,671)
Change in derivative liabilities    (184,084)
Other 24,813 (14,637)
Total other expense, net (336,772) (482,659)
Net loss (7,341,019) (6,989,072)
Preferred stock dividends    (25,000)
Net loss attributable to common stockholders $ (7,341,019) $ (7,014,072)
Loss per common share (basic and diluted) $ (0.06) $ (0.07)
Weighted average shares outstanding (basic and diluted) 113,763,600 94,074,918